NEWS
Our Latest News
ARCHIMED MedTech announces the definitive acquisition of Global Dental Technology Platform, ZimVie
ARCHIMED MedTech – the MedTech team of global private equity healthcare specialist ARCHIMED – announces the take-private acquisition of NASDAQ-listed ZimVie (NASDAQ: ZIMV), which spun out of Zimmer Biomet in 2022. This investment was made through ARCHIMED’s top performing MED Platform II Fund.
ARCHIMED MedTech announces the acquisition of Global Dental Technology Platform, ZimVie
October
20,
2025
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
October
15,
2025
ARCHIMED acquires cell line development pioneer ExcellGene to accelerate expansion into biosimilars and high-performance transfection solutions
September
25,
2025
368